Document is current
Any future updates will be listed below
-
Authors
Pincay, Jorge
da Costa, Bruna Lopes
Quinn, Peter M. J.
Rodriguez, Marilyn
Zhou, Ashley
Kong, Maximilian D.
Sparrow, Janet R.
Tsang, Stephen H. https://orcid.org/0000-0001-9082-2427
- License Information
-
More Information
Article History
Received: 2 July 2024
Accepted: 10 March 2025
First Online: 4 April 2025
Declarations
:
: S.H.T receives financial support from Abeona Therapeutics, Inc and Emendo and is on the scientific and clinical advisory board for Nanoscope Therapeutics. Peter M.J. Quinn is supported by the Curing Retinal Blindness Foundation (CRBF), a Foundation Fighting Blindness Individual Investigator Research Award, and the NIH R01EY034952. J.P., B.L.D, M.R., A.Z, M.D.K., and J.R.S. have no conflicting interests.
: The study was conducted under the Columbia University Institutional Review Board-approved protocol IRB AAAR8743, and all procedures were performed in accordance with the tenets of the Declaration of Helsinki.
: Informed consent was waived due to the retrospective nature of the study and the minimal risk conferred to patients as per the Columbia University Institutional Review Board-approved protocol AAAR8743.
: The study was conducted under the Columbia University Institutional Review Board-approved protocol IRB AAAR8743, and all procedures were performed in accordance with the tenets of the Declaration of Helsinki.
: No animals were used in the study.
